Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Non-melanoma Skin Cancer 2Lung Neoplasms 2Keratosis, Actinic 2Urinary Bladder Neoplasms 1Skin Neoplasms 1Respiratory Aspiration 1Prostatic Hyperplasia 1Pneumothorax 1Pleural Neoplasms 1Pleural Effusion 1Photosensitivity Disorders 1Pain, Postoperative 1Pain 1Neurofibromatosis 1 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lower Urinary Tract Symptoms 1Hematuria 1Hand-Foot Syndrome 1Empyema, Pleural 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Celecoxib 2Capecitabine 2tegafur-gimeracil-oteracil 1mecobalamin 1liposomal doxorubicin 1Urea 1Tobacco Use Cessation Devices 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Pyridoxine 1Pharmacokinetics 1Medicine, Chinese Traditional 1Low-Level Light Therapy 1Diclofenac 1Brimonidine Tartrate 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hand-Foot Syndrome × Diclofenac × Clear all
NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

German University in Cairo

Phase 2 Completed
86 enrolled
Breast

Breast Neoplasms, Hand-Foot Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡